(4-methylsulfanyl-phenyl)-thiophen-2-yl-methanol | 356552-80-2

• 分子结构分类: 有机化合物 - 有机硫化合物 - 硫醚类
• 英文名称: (4-methylsulfanyl-phenyl)-thiophen-2-yl-methanol
• 英文别名: 4-Methylthiophenyl-(2-thienyl)methanol；(4-methylsulfanylphenyl)-thiophen-2-ylmethanol
• CAS: 356552-80-2
• 化学式: C₁₂H₁₂OS₂
• 分子量: 236.359
• InChiKey: TUHKCMUECMWDEQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  73.8
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (4-methylsulfanyl-phenyl)-thiophen-2-yl-methanol 在 硫酸 、 potassium carbonate 作用下， 以 丙酮 、 苯 为溶剂， 生成 N-isopropyl-N-(2-(4-((4-(methylthio)phenyl) (thiophen-2-yl)methyl)phenoxy)ethyl)propan-2-amine
  参考文献：
  名称：

  Thiophene containing trisubstituted methanes [TRSMs] as identified lead against Mycobacterium tuberculosis

  摘要：

  Triarylmethanes (TRAMs) and thiophene containing trisubstituted methanes (TRSMs) have been reported by us, having potential against Mycobacterium tuberculosis and Mycobacterium fortuitum strains, respectively. Further, extension through synthesis and biological evaluation of novel TRSMs resulted into an identified lead 36 (S006-830) [(diisopropyl-(2-{4-[(4-methoxy-phenyl)- thiophen-2-yl-methyll-phenoxy}-ethyl)-amine)] with MIC: 1.33 mg/L, non-toxic against Vero C-1008 cell line with selectivity index >10, ex vivo efficacy equivalent to first line TB drugs-isoniazid (INH), rifampicin (RFM) and pyrazinamide (PZA) in the mouse and human macrophages, and lung CFU count of 2.2 x 10(7) (approximately 15 fold lesser than untreated mice, 31 x 10(7)) with efficacies comparable to ethambutol (EMB) (1.27 x 10(7)) and PZA (1.9 x 10(7)). Further, S006-830 also showed potent bactericidal activity against multi-drug resistant and single-drug resistant clinical isolates of M. tuberculosis. (C) 2015 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2015.03.036
• 作为产物：
  描述：

  4-溴茴香硫醚 在 magnesium 作用下， 以 四氢呋喃 为溶剂， 反应 0.5h， 以74%的产率得到(4-methylsulfanyl-phenyl)-thiophen-2-yl-methanol
  参考文献：
  名称：

  含有三芳基甲烷的噻吩作为抗结核药。

  摘要：

  由二芳基甲醇的弗瑞德-克来福特烷基化反应，然后结合氨基烷基链，合成了一系列新的含噻吩的三芳基甲烷衍生物。对它们进行了针对结核分枝杆菌H37R（v）的评估，并在体外显示其活性在3.12-12.5 microg / mL的范围内。

  DOI：

  10.1016/j.bmcl.2007.10.083

文献信息

• Panda, Gautam; Parai, Maloy Kumar; Srivastava, Ajay Kumar, Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2009, vol. 48, # 8, p. 1121 - 1127
  作者：Panda, Gautam、Parai, Maloy Kumar、Srivastava, Ajay Kumar、Chaturvedi, Vinita、Manju、Sinha, Sudhir

  DOI：——

  日期：——
• Thiophene containing trisubstituted methanes [TRSMs] as identified lead against Mycobacterium tuberculosis
  作者：Priyanka Singh、Sudipta Kumar Manna、Amit Kumar Jana、Tiash Saha、Pankaj Mishra、Saurav Bera、Maloy Kumar Parai、Srinivas Lavanya Kumar M、Sankalan Mondal、Priyanka Trivedi、Vinita Chaturvedi、Shyam Singh、Sudhir Sinha、Gautam Panda

  DOI：10.1016/j.ejmech.2015.03.036

  日期：2015.5

  Triarylmethanes (TRAMs) and thiophene containing trisubstituted methanes (TRSMs) have been reported by us, having potential against Mycobacterium tuberculosis and Mycobacterium fortuitum strains, respectively. Further, extension through synthesis and biological evaluation of novel TRSMs resulted into an identified lead 36 (S006-830) [(diisopropyl-(2-4-[(4-methoxy-phenyl)- thiophen-2-yl-methyll-phenoxy}-ethyl)-amine)] with MIC: 1.33 mg/L, non-toxic against Vero C-1008 cell line with selectivity index >10, ex vivo efficacy equivalent to first line TB drugs-isoniazid (INH), rifampicin (RFM) and pyrazinamide (PZA) in the mouse and human macrophages, and lung CFU count of 2.2 x 10(7) (approximately 15 fold lesser than untreated mice, 31 x 10(7)) with efficacies comparable to ethambutol (EMB) (1.27 x 10(7)) and PZA (1.9 x 10(7)). Further, S006-830 also showed potent bactericidal activity against multi-drug resistant and single-drug resistant clinical isolates of M. tuberculosis. (C) 2015 Elsevier Masson SAS. All rights reserved.
• Thiophene containing triarylmethanes as antitubercular agents
  作者：Maloy Kumar Parai、Gautam Panda、Vinita Chaturvedi、Y.K. Manju、Sudhir Sinha

  DOI：10.1016/j.bmcl.2007.10.083

  日期：2008.1

  A new series of thiophene containing triarylmethane derivatives were synthesized from the Friedel-Crafts alkylation of diarylcarbinols followed by incorporation of amino alkyl chains. These were evaluated against Mycobacterium tuberculosis H37R(v) and showed the activity in the range of 3.12-12.5 microg/mL in vitro.

  由二芳基甲醇的弗瑞德-克来福特烷基化反应，然后结合氨基烷基链，合成了一系列新的含噻吩的三芳基甲烷衍生物。对它们进行了针对结核分枝杆菌H37R（v）的评估，并在体外显示其活性在3.12-12.5 microg / mL的范围内。